eNewsroom for: Replikins

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Replikins/index01.jpg

Replikins Company Profile

Replikins, Ltd. develops and markets novel forecasting tools and synthetic vaccines to fight virulent rapidly replicating diseases including bird flu, malaria, and HIV. The company's predictive products and vaccines in development are based upon the company's discovery of Replikins, a new group of peptides related to the rapid replication function in viral and other diseases. The company has designed unique products to predict the emergence of virulent strains of particular diseases (FluForecastâ„¢) and is designing synthetic vaccines specifically tailored to combat a given strain and against shared properties of several strains (Syntopeâ„¢ vaccines). The company is partnering with governments and the private sector in providing predictive tools and vaccines in furtherance of the public health initiative to prevent and combat epidemics.

News from Replikins:

Anti-Microcephaly Vaccine–Blocker Candidate: Based on Zika Virus Gene Replikins in Human Fetal Microcephaly

TORONTO, Aug. 2, 2016 /PRNewswire/ — Following the report earlier this month that significant mutations have been detected in Zika gene structures*, Replikins, Ltd. Canada announced today that particular Replikins structures have been found in the Zika virus genes of microcephaly cases. L…

Zika Virus Gene Replikins: Significant Mutations Detected

Surveillance Service and Delivery in 7-Days of New Commensurate 'Made to Measure' Vaccine-Blocker Candidates TORONTO, July 11, 2016 /PRNewswire/ — Replikins Ltd. announced today that recent rapid significant Zika virus gene mutations have been detected and quantified by Repl…

First Response to Zika Replikins Vaccine Candidates Reported

Two vaccines synthesized in seven days, Immune response in 21 days TORONTO, May 5, 2016 /PRNewswire/ — Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine candidates. Logo – http://photos.prnewswire.com/prnh/20160505/364344LOGO Photo…

Increases in Ebola and Zika Gene Replikin Counts for 2012 and 2013 Gave 1-3 Year Warning Before their Respective Outbreaks in 2014 and 2015

New Replikins Surveillance Service™, Now Available to Institutions & Individuals, Can Hasten Specific Pandemic Prevention Efforts Before the Next Outbreak of These and Other Zoonotic Disorders BOSTON, May 2, 2016 /PRNewswire/ — Replikins, Ltd. today announced the provision of a ne…

Zika, Dengue and Japanese-Encephalitis Trivalent Synthetic Replikins Vaccine-Blocker Candidate Being Tested in Animals, with July 2016 Goal to Begin Human Trials

TORONTO, April 12, 2016 /PRNewswire/ — Replikins, Ltd, today announced an understanding of the evolution of lethal virus gene structures in Zika and closely related Flaviviruses. This genomic understanding has led to the development of a trivalent vaccine for Zika, Dengue and Japanese Enceph…

Zika Gene Replikin Count at Highest Level Observed

Replikins Ltd. To Begin Testing Zika Synthetic Vaccine BOSTON, Jan. 26, 2016 /PRNewswire/ — Replikins, Ltd. announced today that sequences in the Zika gene have been found to be at the highest levels observed since 1947. Retrospective genomic analysis of the Zika gene shows marked changes in t…

Ebola Is Back: New Genetic Analysis Using Replikins GeneForecast™ Detected a Two-Fold Increase in Gene Replikin Counts

LONDON, July 15, 2015 /PRNewswire/ — Replikins Ltd announced today that after analyzing one year of the lowest pre-outbreak Ebola gene Replikin Counts, quantitative automated Replikins, GeneForecast™ has detected a two-fold increase (p<0.001) in the gene Replikin Counts of each of t…

MERS-Corona Virus Gene Replikins Significantly Increased in Both Camels and Humans; Associated with Rapid Virus Replication

Replikins Vaccine Consortium MERS Vaccine-Blocker Candidate Immunogenic in Animals Now Available to Institutions for Challenge Testing LONDON, June 16, 2015 /PRNewswire-USNewswire/ — Keiji Fukuda, WHO assistant director-general for health security, quoted by the Ministry of Health, So…

MERS and Ebola Replikins Synthetic Vaccine-Blocker™ Candidates Presented at Meeting of Int’l Society for Neglected Tropical Diseases at Wellcome Trust May 20th

Predictions Based on Over 3 Million Automated Quantitative Gene Sequence Analyses Freeze-dried Vaccine-Blocker Candidates Now Available for Challenge Testing LONDON, June 4, 2015 /PRNewswire/ — Replikins Ltd. presented MERS and Ebola Synthetic Vaccine-Blocker candidates at a meeting…

New Analyses of Nearly 900,000 Genetic Sequences of Ebola Polymerase, VP35, and Glycoprotein Reveals Replikin Count Increase in 2012-13 — One Year in Advance of the Ebola Outbreak

This Was Followed by A Sudden Decrease in Replikin Count and the Rapid Decline in Number of New Ebola Cases Throughout 2014; Ebola Replikin Count has Begun to Rise Again in 2015 LONDON, April 15, 2015 /PRNewswire-USNewswire/ — Replikins Ltd reported today that 886,277 automated analyses of Ebola…

Analysis of Virus Gene Replikin Counts Offers Advance Look at Specifics of Next Outbreaks & Pandemics

Current Discussions in Davos Emphasize Importance of Finding New Tools for Preparedness LONDON, Jan. 29, 2015 /PRNewswire/ — Changes in the Ebola gene in 2013 predicted the 2014 outbreaks of Ebola. Changes in the gene in 2014 predicted Ebola's cessation (see attached Figure and Reprint…

On the Deficient Current Flu Vaccine:

H3N2 Genomic Warning by Replikins Technology Each of Three Years in Advance LONDON, Dec. 30, 2014 /PRNewswire/ — A 'surprise' clinical appearance of a 'new' H3N2 influenza strain in 2014 flu cases was first reported late in 2014. The observation came too late to have the n…

Viruses' Advantage of Surprise is Lost

Gene Replikin Count Shown to Increase 1-2 Years in Advance of Outbreaks of Influenza (H1N1, H5N1, H7N9, and H3N2), SARS, Mers-CoV, Foot and Mouth Disease, Hand Foot and Mouth Disease, Ebola, Dengue Fever and Chikungunya LONDON, Nov. 21, 2014 /PRNewswire/ — The element of surprise has been a major…

Marked Increase in Ebola Gene Replikin Count in 2012 & 2013 Predicted Current Ebola Outbreak; Does Recent Sharp Drop in Replikin Count Signal Early End for the Current Ebola Outbreak?

Replikins Global Surveillance System™ Data to be presented at Boston University School of Medicine, Distinguished Speaker Series on October 14, 2014. LONDON, Oct. 8, 2014 /PRNewswire/ — Replikins Global Surveillance System™ analysis of the Ebola virus show the highest ever peaks…

Mers CoV Virus Gene Replikins Found Conserved and Shared in Current Strains Back to 2012

New Analysis Provides Basis for a Synthetic Mers CoV Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ — An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Mers CoV virus strains has revealed extensive conservation and sharing of spe…

Influenza H1N1 Virus Gene Replikins Found Conserved and Shared in Current Strains Back to 1918

New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ — An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Influenza H1N1 virus strains has revealed extensive conservation…

Ebola Virus Gene Replikins Found Conserved and Shared in All Ebola Strains Back to 1976

Latest Analysis Provides Basis for a Synthetic Ebola Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ — An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Ebola strains has revealed extensive conservation and sharing of specif…

Dengue Virus Gene Replikins Found Conserved and Shared in Current Dengue Strains Back to 1944

New Analysis Provides Basis for a Synthetic Dengue Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ — An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Dengue virus strains in Pubmed, has revealed extensive conservation and shari…

Chikungunya Virus Gene Replikins Found Conserved and Shared in Current Chikungunya Strains Back to 1953

New Analysis Provides Basis for a Synthetic Chikungunya Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ — An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Chikungunya virus strains has revealed extensive conservation and shar…

Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks

LONDON, July 30, 2014 /PRNewswire/ — Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and 2002 was 1.1; the mean Replikin Coun…

Human Mers-CoV Specimens in Florida and Indiana Found to Contain Identical Replikins Gene Sequences to Replikins of Other Countries

Global Target Established: Replikins Identical in Humans and Camels; Anti-Mers-CoV Replikins Vaccine™ Available and Testing Has Started LONDON, May 19, 2014 /PRNewswire/ — In an analysis of the human specimen gene sequences published Saturday, May 17 by PubMed, Bioradar UK, Ltd. found the…

Identical Shared Replikins Found Conserved from 2012 to 2014 in the Genes of Mers-CoV Virus Infecting Camels and Humans

Anti-Mers-CoV Synthetic Replikins Vaccine™ Available Now to Vaccinate Camels LONDON, May 16, 2014 /PRNewswire/ — A Replikins analysis by Bioradar, Ltd of Mers-CoV in all isolates of the virus genes reported to date in Pubmed from both humans and camels has revealed specific shared gene Repli…

Mers-CoV ‘On Course’ According to the Published Genomic Replikin Count Predictions of 2012 and 2013

Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009 Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today LONDON, April 30, 2014 /PRNewswire/ — Bioradar UK…

Increased Risk of H1N1 (Swine Flu) Pandemic #3 Found in Replikins Gene FluForecast®

Completely Synthetic Replikins Vaccine H1N1Pan3™ Is Available Now LONDON, Dec. 31, 2013 /PRNewswire/ — Bioradar UK Ltd. announced today that analysis of 35,529 sequences in two H1N1 Replikins genes, from 1918 to 2013, indicates that the risk of a third H1N1 (Swine Flu) pandemic has inc…

Drop in Gene Replikin Counts of Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) Suggests Decrease in Risk of Pandemic, but Counts Rise Again

Bioradar UK Ltd. Cautions Against Relaxing Public Health Measures Given Four-Month Lag in Available Data, Lessons from SARS LILLE, France, Oct. 21, 2013 /PRNewswire/ — Bioradar UK Ltd. announced today at the Vaccine Congress Europe in Lille that quantitative real-time Replikins Analysis o…

New Genomic Analysis Shows H5N1 (Bird Flu) Replikin Count Highest Among Five Influenza Strains

Elevated Threat of Pandemic; Candidate Replikins Vaccines to be announced at World Vaccine Congress Europe October 16-17, 2013, Lille France LONDON, Oct. 9, 2013 /PRNewswire/ — Replikins are specific gene structures quantitatively related to rapid replication and outbreaks of viruses (1).…

Details of New Synthetic Vaccine for Emerging H7N9 Threat Revealed at BIO International Convention in Chicago, April 22-25

LONDON, April 18, 2013 /PRNewswire/ — Replikins Ltd will reveal details on the availability of two completely synthetic vaccine candidates, both with long-term prevention goals and acute short-term blocking capacity.  One of these vaccines targets H7N9 alone, the other for H7N9 plus the o…

H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready for Testing to Prevent Possible Pandemic

LONDON, April 9, 2013 /PRNewswire/ — Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died fr…

H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready for Testing to Prevent Possible Pandemic

LONDON, April 9, 2013 /PRNewswire/ — Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died fr…

Future Course of New Lethal Avian Flu Outbreak in China Can Be Predicted

Will H7N9 Follow Limited Course of SARS or Longer Course of H1N1 Pandemic? Can a Potential Pandemic Be Prevented? LONDON, April 8, 2013 /PRNewswire/ — Bioradar UK Ltd. and Replikins Ltd. today announced that when the full H7N9 virus genomic sequences from the first lethal and surviving human case…

Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria

Replikins Synthetic Vaccines Against Antibiotic-Resistant Gonococcus, Tuberculosis, Staphylococcus, Streptococcus, Klebsiella KPC, and Cl. Difficile OTTAWA, Ontario, March 14, 2013 /PRNewswire/ — A group of lethal bacteria are of increasing concern worldwide because they are becom…

Recent Outbreak of Hand-Foot-Mouth Disease in 2.2 Million Children (WHO) Preceded and Predicted by Increase in the HFMD Genomic Replikin® Count

LONDON, Feb. 19, 2013 /PRNewswire/ — Bioradar UK Ltd has found that the virus genomic Replikin® Count in Hand-Foot-Mouth Disease (HFMD) increased fourfold worldwide from 2005 to 2012 (Figure). All HFMD genomes on Pubmed were analyzed for Replikins (References). Increase in the genomic Rep…

New Shared Synthetic Replikin Cancer Vaccines

Conserved Genomic Replikin Peptides were found to be Shared in Histologically Different  Common Lethal Human Cancers BOSTON, Jan. 22, 2013 /PRNewswire/ — Replikins Ltd. and Brain Research Associates announced today that specific conserved genomic Replikin peptide sequences for the first…

Replikin Count of Influenza H3N2 Replikin Lethality Gene in the U.S. Approaches That of 1968 H3N2 Pandemic

LONDON, Jan. 16, 2013 /PRNewswire/ — Bioradar UK Ltd this week reported that the H3N2 Lethality Gene Counts are approaching those of the highly lethal H3N2 pandemic of 1968 (1)(see Figure). (Photo: http://photos.prnewswire.com/prnh/20130116/PH43879-INFO ) The severe flu outbreaks…

2012 'State Fair' Swine Flu H3N2 Outbreak in U.S. Was Correctly Predicted by Increase in Genomic Replikin®Count Two Years Earlier

Can New Synthetic Replikin TransFlu Vaccines Prevent 2013-14 Swine Outbreak?   Advanced Flu Prediction and New Synthetic Vaccines Offer Government Important New Tools to Prevent Pandemics from Developing LONDON, Nov. 29, 2012 /PRNewswire/ — Bioradar UK Ltd today concluded that an increas…

Five New Cases of SARS-like Virus Bring Total to Seven, Prompting Calls for Immediate Trials of New Synthetic Replikin™Vaccine SARS2012

BioRadar UK Ltd. Warned on Oct. 5 of Rise in Human SARS Virus Genomic Replikin™Count to Levels that Preceded the 2003 Lethal SARS Outbreak LONDON, Nov. 27, 2012 /PRNewswire/ — The World Health Organization (WHO) last week reported that four new cases of SARS-like virus have been found in Saudi Ar…

The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC

Highest Ever ReplikinCounts in H5N1 HA and p B1 Genes in 2010 and 2011 Predict Increased Infectivity and Lethality   Replikins TransFlu™Vaccine Updated LONDON, Nov. 6, 2012 /PRNewswire/ — In the lead paper to be presented at the Influenza Congress USA in Washington DC on November 12, 2012…

Human SARS Virus Genomic Replikin™ Count Rises to the Level that Preceded the 2003 Lethal SARS Outbreak

SyntheticReplikin™ VaccineSARS 2012 Now Available for Testing Can the SARS virus return? An analysis of the current virus's genomic Replikin Count has revealed the Count to be increased significantly above the preceding low 'resting' levels 2004-2011. The Count is now in the same…

Discovered Evolution of Genomic Sequences — from Ocean Archaea to Brain Cancer — Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer

New Book Due in September 2012 LONDON, June 19, 2012 — The Foundation for Research on the Nervous System, Replikins Ltd., and Bioradar UK Ltd. today announced that over 100 new synthetic Replikins vaccines for infectious diseases and cancer are now available as a result of the discovery by scienti…

Current H5N1 Flu Outbreak and Location Predicted in 2009

Cambodian Avian Flu Marks Fifth Time an Increase in the Flu Strain's Replikins Count® Foretold a (Preventable) Viral Outbreak LONDON, Feb. 10, 2012 — Bioradar UK Ltd. reported today the fifth instance in which the specific strain and specific location of an influenza outbreak were predic…

FAO Warnings Follow Rise in Replikins Count for Both H5N1 and Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested

U.N. Food and Agriculture Organization Warns of 'Possible Major Resurgence' of Avian Flu (H5N1) in Asia and a New Vaccine-Evading Strain in Vietnam and China LONDON, Aug. 31 2011 — The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a ma…

U.N. Food and Agriculture Organization Warns of 'Possible Major Resurgence' of Avian Flu (H5N1) in Asia and a New Vaccine-Evading Strain in Vietnam and China

FAO Warnings Follow Rise in Replikins Count for Both H5N1 and Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested LONDON, Aug. 31 2011 — The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a matter of global concern (1, 2). Bioradar UK…

Rising Replikin Counts in E. Coli in Germany Since 2005 Preceded Current E. Coli Outbreak

Synthetic Replikins Therapeutics for E. Coli Now Available for Testing LONDON, June 20, 2011 — Scientists Drs. Samuel and Elenore Bogoch of BioRadar UK Ltd. announced that retrospective studies indicate that an increase in Replikin Counts of the EHEC lethal strains of E. Coli preceded the curre…

New Finding of Rise in H5N1 Virus (Avian Flu) Replikin Count

Replikins Global BioRadar Surveillance System™ Shows Replikin Count in H5N1 at Record High for 2010 BOSTON, Oct. 27, 2010 — BioRadar™ software correctly predicted the 2009 H1N1 (Swine Flu) outbreak a year in advance (http://www.replikins.com, Replikins Press, 2008). The same rise in Rep…

Current Severe Outbreaks of Foot and Mouth Disease Predicted by Replikins' BioRadar(TM) One Year in Advance (June 2009)

Replikins TransFoot and Mouth Disease (FMD) Vaccine(TM) Now Available; Highest Replikin Count in FMDV in 52 Years Found in 2009 LONDON, July 16, 2010 — BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Cou…

Both H5N1 Bird Flu and H1N1 Swine Flu Replikin Counts(TM) Are Increasing

H5N1 Outbreaks, Predicted One Year Ago by BioRadar(TM), Now Appear in 63 Countries; TransFlu(TM) Vaccine Shown Effective Against H5N1 in Chickens LONDON, April 9, 2010 — The most recent BioRadarTM (FluForecastTM) analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, k…

Replikins' BioRadar(TM) Announced by UK Trade and Investment

Flu Pandemic Warning Company Sets Up in UK LONDON, March 29, 2010 — UK Trade and Investment ) has announced the formation of BioRadar UK Limited. BioRadar is building on the recent success of Replikins' genomic analysis of influenza viruses in predicting the outbreaks of both H5N1 (bird flu)…

Biological H1N1 Vaccines: Too Little, Too Late

Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle – Virus' Infectivity Remains Increased; New Faster-Developed Synthetic Replikin Vaccines Found Effective, FluForecast(R) Gives Advance Warning of Strain-Specific Outbreaks and Cessation B…

New Non-Biological Synthetic Replikins(TM) Vaccines Shown to Be Effective and Fast; WorldVaccines(TM), Ltd Formed for Testing and Distribution

Old Biological Vaccines for Emergent Diseases — Too Little, Too Late BOSTON, Oct. 19, 2009 — There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging di…

Lethality of H1N1 Influenza Virus Increasing According to Latest Analysis of Virus Peptide Genomic Data

Boston Biotech Firm Reports First Rise in 76 Years of Replikin Count* of H1N1 Lethality Gene BOSTON, June 10, 2009 — An analysis of the latest peptide genomic data for the H1N1 influenza virus indicates that the current global outbreak of H1N1 is increasing in its capacity for lethality. The new seq…

First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide

LONDON, May 4, 2009 — A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandem…

Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 'Swine Flu' Virus Outbreak

BOSTON, April 27, 2009 — Replikins Ltd. published a FluForecast(R) warning in April 7th, 2008, a year before the recent Mexico and California H1N1 cases. The company was able to state the likelihood of H1N1 outbreaks based on its patented Replikin Count(TM) genomics technology, which examines s…

Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data

BOSTON, March 20, 2009 — Replikins, Ltd. announced today that data recently published from Harvard-CDC and Scripps-Crucell in Nature(1) and Science(2) confirms the 2001 discoveries by Dr. Samuel and Elenore Bogoch of peptides in the hemagglutinin unit of influenza, which they named Replikin…

A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks

BOSTON, Nov. 12, 2008 — WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" — often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predict…